Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

776
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
776
Tissue Transplantation01:24

Tissue Transplantation

827
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
827
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.1K
Overview
83.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Staphylococcal proliferation on skin models to investigate novel anti-infective treatments against dysbiosis.

Bioengineering & translational medicine·2026
Same author

The Phenotype List String Grammar for Enhanced Protein and Antigen Reporting in the Immunogenetic Context.

HLA·2026
Same author

Mechanochemical Methods for Amide Bond Formation.

Chemical reviews·2026
Same author

HERA: a web server for host element reference-based aligner.

Nucleic acids research·2026
Same author

RegRegSEA: a web server for regulatory region set enrichment analysis of epigenomic data.

Nucleic acids research·2026

Related Experiment Video

Updated: Dec 31, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.5K

Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).

Alexander H Schmidt1,2,3, Jürgen Sauter1, Daniel M Baier1

  • 1DKMS, Tübingen, Germany.

International Journal of Immunogenetics
|January 7, 2020
PubMed
Summary

Stem cell registries like DKMS facilitate life-saving transplants by managing millions of donors. This review focuses on immunogenetics and population genetics in optimizing donor registries for HLA diversity.

Keywords:
DKMSHLAdonor registryunrelated hematopoietic stem cell transplantation

More Related Videos

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
10:11

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

15.8K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.7K

Related Experiment Videos

Last Updated: Dec 31, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.5K
Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
10:11

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

15.8K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.7K

Area of Science:

  • Immunogenetics
  • Population Genetics
  • Hematopoietic Stem Cell Transplantation

Background:

  • Over 35 million potential donors are registered globally for unrelated stem cell transplants.
  • DKMS is a major registry with over 9 million donors and more than 80,000 hematopoietic stem cell donations.
  • Donor registry operations intersect significantly with immunogenetics and population genetics.

Purpose of the Study:

  • To review the role of immunogenetics and population genetics in stem cell donor registries.
  • To analyze DKMS's operations, focusing on HLA typing, haplotype frequencies, and donor file optimization.
  • To provide insights into enhancing HLA diversity within donor registries.

Main Methods:

  • Overview of DKMS operations and donor registry activities.
  • Focus on high-throughput HLA typing methodologies for potential stem cell donors.
  • Analysis of HLA haplotype frequencies and their impact on matching probabilities.
  • Strategies for optimizing donor files to maximize HLA diversity.

Main Results:

  • DKMS manages a substantial donor pool across multiple countries.
  • High-throughput HLA typing is crucial for efficient donor selection.
  • Understanding HLA haplotype frequencies improves the probability of finding matched donors.
  • Optimizing donor files for HLA diversity increases transplant success rates.

Conclusions:

  • Stem cell donor registries play a vital role in facilitating unrelated donor transplants.
  • Immunogenetic and population genetic principles are essential for effective registry management.
  • Strategies focusing on HLA diversity are key to improving patient access to matched donors.